Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials
- DOI
- 10.1038/s41591-026-04739-2
- Published
- 2026-11-02
- Container
- Nature Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-026-04739-2,
title = {Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials},
author = {Khaled Ezzedine and Harvey Lui and Viktoria Eleftheriadou and Seemal R. Desai and Thierry Passeron and Julien Ringuet and Nanja van Geel and Albert Wolkerstorfer and Charles Lynde and Matthias Augustin and José Luis López-Estebaranz and Pearl Grimes and David Rosmarin and Kurt Brown and Shaoceng Wei and Sunanda Karanam and Deanna Kornacki and Amit G. Pandya},
year = {2026},
journal = {Nature Medicine},
doi = {10.1038/s41591-026-04739-2},
url = {https://doi.org/10.1038/s41591-026-04739-2}
}RIS
TY - JOUR TI - Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials AU - Khaled Ezzedine AU - Harvey Lui AU - Viktoria Eleftheriadou AU - Seemal R. Desai AU - Thierry Passeron AU - Julien Ringuet AU - Nanja van Geel AU - Albert Wolkerstorfer AU - Charles Lynde AU - Matthias Augustin AU - José Luis López-Estebaranz AU - Pearl Grimes AU - David Rosmarin AU - Kurt Brown AU - Shaoceng Wei AU - Sunanda Karanam AU - Deanna Kornacki AU - Amit G. Pandya PY - 2026 JO - Nature Medicine DO - 10.1038/s41591-026-04739-2 UR - https://doi.org/10.1038/s41591-026-04739-2 ER -
APA
Ezzedine, K., Lui, H., Eleftheriadou, V., Desai, S. R., Passeron, T., Ringuet, J., Geel, N. V., Wolkerstorfer, A., Lynde, C., Augustin, M., López-Estebaranz, J. L., Grimes, P., Rosmarin, D., Brown, K., Wei, S., Karanam, S., Kornacki, D., & Pandya, A. G. (2026). Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials. Nature Medicine. https://doi.org/10.1038/s41591-026-04739-2
Source records
- crossref · retrieved 2026-11-05T17:34:49.167Z